Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 34% ± 14% | |
endothelial cell | 13 studies | 30% ± 13% | |
microglial cell | 12 studies | 36% ± 13% | |
oligodendrocyte | 12 studies | 28% ± 11% | |
macrophage | 11 studies | 28% ± 14% | |
plasmacytoid dendritic cell | 10 studies | 30% ± 10% | |
oligodendrocyte precursor cell | 10 studies | 29% ± 12% | |
B cell | 9 studies | 19% ± 7% | |
glutamatergic neuron | 8 studies | 40% ± 27% | |
dendritic cell | 8 studies | 29% ± 11% | |
fibroblast | 8 studies | 27% ± 14% | |
epithelial cell | 7 studies | 32% ± 21% | |
myeloid cell | 7 studies | 24% ± 6% | |
GABAergic neuron | 7 studies | 40% ± 20% | |
interneuron | 6 studies | 37% ± 24% | |
adipocyte | 6 studies | 25% ± 5% | |
ciliated cell | 5 studies | 22% ± 6% | |
endothelial cell of lymphatic vessel | 5 studies | 25% ± 8% | |
monocyte | 5 studies | 24% ± 6% | |
smooth muscle cell | 5 studies | 24% ± 2% | |
neuron | 4 studies | 28% ± 12% | |
memory B cell | 4 studies | 17% ± 1% | |
naive B cell | 4 studies | 19% ± 3% | |
lymphocyte | 4 studies | 27% ± 11% | |
Mueller cell | 4 studies | 26% ± 16% | |
retinal rod cell | 4 studies | 26% ± 6% | |
T cell | 4 studies | 20% ± 3% | |
club cell | 4 studies | 22% ± 9% | |
pericyte | 4 studies | 30% ± 14% | |
classical monocyte | 3 studies | 21% ± 4% | |
conventional dendritic cell | 3 studies | 30% ± 7% | |
non-classical monocyte | 3 studies | 18% ± 3% | |
plasmablast | 3 studies | 28% ± 9% | |
GABAergic interneuron | 3 studies | 20% ± 4% | |
granule cell | 3 studies | 21% ± 4% | |
plasma cell | 3 studies | 35% ± 4% | |
mesothelial cell | 3 studies | 28% ± 8% | |
glycinergic amacrine cell | 3 studies | 19% ± 5% | |
basal cell | 3 studies | 38% ± 24% | |
hepatocyte | 3 studies | 40% ± 27% | |
ependymal cell | 3 studies | 33% ± 9% | |
alveolar macrophage | 3 studies | 30% ± 8% | |
natural killer cell | 3 studies | 20% ± 2% | |
type I pneumocyte | 3 studies | 22% ± 7% | |
type II pneumocyte | 3 studies | 23% ± 6% | |
gamma-delta T cell | 3 studies | 19% ± 2% | |
regulatory T cell | 3 studies | 17% ± 3% | |
goblet cell | 3 studies | 36% ± 27% | |
transit amplifying cell | 3 studies | 39% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6954.43 | 1442 / 1445 | 100% | 28.08 | 183 / 183 |
lung | 100% | 7357.03 | 577 / 578 | 99% | 18.83 | 1142 / 1155 |
intestine | 100% | 7410.31 | 966 / 966 | 98% | 15.97 | 518 / 527 |
stomach | 100% | 5612.28 | 359 / 359 | 98% | 18.27 | 280 / 286 |
breast | 100% | 7662.30 | 459 / 459 | 98% | 21.20 | 1094 / 1118 |
bladder | 100% | 7473.29 | 21 / 21 | 98% | 16.17 | 493 / 504 |
prostate | 100% | 6679.88 | 245 / 245 | 96% | 17.39 | 482 / 502 |
uterus | 100% | 8458.47 | 170 / 170 | 96% | 17.16 | 440 / 459 |
pancreas | 99% | 3840.55 | 325 / 328 | 97% | 17.62 | 172 / 178 |
thymus | 100% | 7202.55 | 651 / 653 | 96% | 17.57 | 578 / 605 |
kidney | 100% | 3997.72 | 89 / 89 | 95% | 17.37 | 854 / 901 |
adrenal gland | 100% | 4619.79 | 257 / 258 | 93% | 11.14 | 214 / 230 |
skin | 100% | 10611.85 | 1809 / 1809 | 91% | 15.12 | 431 / 472 |
ovary | 100% | 9215.52 | 180 / 180 | 91% | 10.40 | 391 / 430 |
liver | 98% | 2930.58 | 222 / 226 | 79% | 9.28 | 322 / 406 |
brain | 73% | 1967.72 | 1936 / 2642 | 98% | 19.02 | 693 / 705 |
spleen | 100% | 7145.21 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.88 | 1 / 1 |
adipose | 100% | 7068.67 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7386.56 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 3311.83 | 786 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 18.82 | 44 / 45 |
heart | 92% | 3127.43 | 788 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 27.55 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 74% | 9.12 | 59 / 80 |
peripheral blood | 53% | 5066.16 | 490 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035562 | Biological process | negative regulation of chromatin binding |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006338 | Biological process | chromatin remodeling |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0140658 | Molecular function | ATP-dependent chromatin remodeler activity |
GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
GO_0017025 | Molecular function | TBP-class protein binding |
GO_0004386 | Molecular function | helicase activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | BTAF1 |
Protein name | TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172) BTAF1 protein BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa |
Synonyms | TAF172 hCG_19287 |
Description | FUNCTION: Regulates transcription in association with TATA binding protein (TBP). Removes TBP from the TATA box in an ATP-dependent manner. |
Accessions | ENST00000265990.12 [O14981-1] Q2M1V9 O14981 Q8N6J1 Q05C17 Q6PI32 |